Evidence map›Paper›PMID 19152445›Full record

ReviewWorld journal of gastroenterology2009

Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease.

Juan Luis Mendoza, Raquel Lana, Manuel Díaz-Rubio

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Gut microbes · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Genetic Involvement ofInternational journal of molecular sciences · 2021
    Review
  7. Review
  8. Detection of Wood Mice (Microorganisms · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Avian Mycobacteriosis: Still Existing Threat to Humans.BioMed research international · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Pathogenesis of Crohn's disease: Bug or no bug.World journal of gastrointestinal pathophysiology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Juan Luis MendozaInflammatory Bowel Disease Unit, Department of Gastroenterology, Hospital Clínico San Carlos, Universidad Complutense, Madrid 28040, Spain. jmendozah@meditex.es
Raquel Lana
Manuel Díaz-Rubio

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hypothesis postulating that Mycobacterium avium paratuberculosis (MAP) is the cause of Crohn's disease (CD) has been circulating for many years. Advances in molecular techniques, such as polymerase chain reaction and culture methods, have enabled researchers to demonstrate that there is an association between MAP and CD. Recently, genome-wide association studies have identified novel susceptibility genes for CD, which are critical for generation of an adaptive immune response that is protective against intracellular pathogens, including M. tuberculosis infection. However, the role of MAP as a cause of CD suffered a setback with the report that administration of antimycobacterial therapy failed to lead to a sustained response in CD patients. Accordingly, this review sought neither to confirm nor refute this, but instead to survey recent literature on the role of MAP in CD.

Indexed as

Anti-Bacterial AgentsAntibodies, BacterialCrohn DiseaseDNA, BacterialGenetic Predisposition to DiseaseHumansMycobacterium avium subsp. paratuberculosisNod2 Signaling Adaptor ProteinParatuberculosisAnti-Bacterial AgentsAntibodies, BacterialDNA, BacterialNOD2 protein, humanNod2 Signaling Adaptor Protein

Identifiers

PMID19152445
PMCPMC2653362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.